A partnership between Mitacs and Mental Health Research Canada is addressing the mental health challenges of Canadians, almost a quarter of whom report feeling anxious or depressed as a direct result of the COVID-19 pandemic.
When it comes to finding cures for rare diseases and addressing emerging viral infections — like COVID-19 — the traditional pharmaceutical business model just doesn’t cut it. Solutions require global collaboration and open-access research, and that means a new research innovation ecosystem — exactly what the Structural Genomics Consortium (SGC) is building.
Dr. Seyyedarash Haddadi developed a novel, low-cost compound — made from a graphene oxide-silver combination — that can be used as part of a coating material for masks; this material makes them 99.99 percent effective against transmission of COVID-19.
As businesses, municipalities, and not-for-profit organizations face unprecedented challenges during the COVID-19 pandemic, Mitacs’s new offering of Business Strategy Internships serves to support local operations.
Montréal-based small business launches a smartwatch that measures the blood oxygen level, body temperature, and heart rate, enabling early detection of COVID-19 symptoms and support for seniors in residences.
A collaborative project supported by Mitacs utilizes research and industry expertise to produce faster and higher volume of manufacturing solutions for PPE and other products that address transmission of COVID-19.
Mitacs interns have teamed up with iMD Research to create a Bluetooth bracelet that uses artificial intelligence to predict the likelihood that a COVID-19 patient will need to be hospitalized based on their vital signs.